Angiolab, Inc. (XKON:251280)
South Korea · Delayed Price · Currency is KRW 1,795.00
+95.00 (5.59%)
At close: Jul 31, 2026
Angiolab Market Cap
Angiolab has a market cap or net worth of 6.27 billion as of July 31, 2026. Its market cap has decreased by -53.97% in one year.
Market Cap
6.27B
Enterprise Value
n/a
Revenue
702.62M
Ranking
n/a
PE Ratio
n/a
Stock Price
1,795.00
ChartMarket Cap Chart
Since April 5, 2017, Angiolab's market cap has decreased from 8.46B to 6.27B, a decrease of -25.92%. That is a compound annual growth rate of -3.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 6.27B | -27.03% |
| Dec 30, 2025 | 8.59B | -62.64% |
| Dec 30, 2024 | 22.99B | 34.78% |
| Dec 28, 2023 | 17.06B | -12.06% |
| Dec 29, 2022 | 19.40B | -6.10% |
| Dec 30, 2021 | 20.66B | -31.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Epibiotech | 29.50B |
| Quratis | 24.34B |
| Poongjeon Pharmacy CO.,LTD. | 22.46B |
| Shaperon | 19.19B |
| Plumbline Life Sciences | 18.69B |
| Moogene Medi | 18.29B |
| MOA Life Plus | 15.31B |
| NGeneBio | 13.58B |